News

You are here

INJECT-ID
Novosanis receives grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID, in collaboration with living labs Happy...
VAX-ID intradermal drug delivery device
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...
Novosanis will present its VAX-ID™ device platform during BioJapan
"High Frequency Ultrasound to Assess Skin Thickness in Healthy Adults” published in the prestigious peer-reviewed journal VACCINE.
ANTWERP. POWERED BY CREATIVES. unites award-winning designers during their annual exposition . Novosanis and Voxdale were invited to showcase their innovative health care designs: Colli-Pee...
Timothi Van Mulder, Researcher Medical Development and Baekeland PhD Fellow at Novosanis, presented data on adult skin thickness generated using high-frequency ultrasound (poster entitled ‘...
Interested in finding out what your skin looks like on an ultrasound image? Novosanis is looking for volunteers to have their skin scanned by ultrasound. More info here .
Timothi Van Mulder , researcher medical development at Novosanis, succesfully applied for Baekeland funding at the Institute for Science and Technology (IWT). This will allow Timothi to...
In this month's edition of the Flemish magazine "Ondernemers" (Entrepreneurs) by Voka, our CEO Vanessa Vankerckhoven proudly presents our 2 products Colli-Pee & VAX-ID.
Read the story of our VAX-ID now in the magazine of Antwerp University! We're on the cover page!
Innotek supports and guides new business initiatives like Novosanis a while ago. They are an important partner in our development and we would like to thank them for their recent press item.